Eye health products company Bausch + Lomb announced a recent agreement with IDOC, the largest privately held alliance of independent doctors of optometry in the United States. According to the agreement, IDOC will provide its base of over 3,000 members access to ULTRA® replacement contact lenses, Biotrue® ONEday daily disposable hydrogel contact lenses as well as other brands from the Bausch + Lomb specialty vision products portfolio. IDOC members will also receive exclusive pricing and rebate programs, and exceptional support as the organization’s newest industry affiliate.
“Bausch + Lomb is proud to work with doctors and patients to develop innovative products designed for today’s needs, while anticipating the needs for the future. Through this collaboration, Bausch + Lomb expands the availability of our leading vision care products to more independent practices across the U.S. and provides them with the opportunity to fit more patients with our innovative portfolio of lenses, said John Ferris, vice president and general manager, U.S. contact lenses, Bausch + Lomb. “We are pleased to work with IDOC, an organization that shares our vision to provide practitioners and patients with more choices and innovation.”
“As an organization wholly committed to the growth and prosperity of independent optometrists, we are excited to collaborate with an industry leader such as Bausch + Lomb, to offer our members an extended line of advanced lens and specialty vision products from which their patients can truly benefit,” said Dave Brown, president and chief executive officer of IDOC.
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, develops, manufactures and markets over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. IDOC is an optometric alliance committed to the growth and long-term success of independent optometrists.